Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

New York Stock Exchange

Securities & Shareholder Litigation

Our Securities & Shareholder Litigation Practice Group has been recognized by Benchmark Litigation, Best Lawyers in America©, BTI Litigation Outlook and Chambers USA for its experience and success in corporate and securities litigation, including:

  • Securities fraud class actions
  • Shareholder derivative litigation
  • Merger-related litigation
  • SEC investigations/enforcement proceedings
  • Internal investigations
  • Corporate governance disputes
  • Securities-related arbitrations

Our clients include more than 35 publicly traded companies, some of the country's largest privately held companies and their officers, directors, issuers, underwriters, special committees, financial and investment advisers. In recent years, we have represented these clients in connection with corporate transactions valued at more than $75 billion, as well as dozens of litigation matters related to sub-prime structured investment products. We also routinely defend clients in securities-related arbitrations, as well as other forms of alternative dispute resolution, throughout the U.S.

Our experience also includes serving as lead counsel for Special Litigation Committees to effectively and efficiently investigate derivative claims and allegations of breaches of fiduciary duties.

Our Securities & Shareholder Litigation Practice Group has been recognized by Benchmark Litigation, Best Lawyers in America©, BTI Litigation Outlook and Chambers USA for its experience and success in corporate and securities litigation, including:

  • Securities fraud class actions
  • Shareholder derivative litigation
  • Merger-related litigation
  • SEC investigations/enforcement proceedings
  • Internal investigations
  • Corporate governance disputes
  • Securities-related arbitrations

Our clients include more than 35 publicly traded companies, some of the country's largest privately held companies and their officers, directors, issuers, underwriters, special committees, financial and investment advisers. In recent years, we have represented these clients in connection with corporate transactions valued at more than $75 billion, as well as dozens of litigation matters related to sub-prime structured investment products. Our team has significant experience resolving insurance coverage disputes, including working with D&O insurance carriers and their counsel on securities litigation matters filed against corporate and director/officer clients.  We also routinely defend clients in securities-related arbitrations, as well as other forms of alternative dispute resolution, throughout the U.S.

Our experience also includes serving as lead counsel for Special Litigation Committees to effectively and efficiently investigate derivative claims and allegations of breaches of fiduciary duties.

While we take great pride in our record of favorably resolving cases through both dispositive motions and favorable settlements, we have an equally impressive record of success in taking these complex litigation matters to trial. For example, in one of the first credit crisis-related trials in the country, we obtained an order of specific performance for our client, Genesco Inc., in connection with a proposed $1.6 billion merger with The Finish Line, Inc.

+ Read More

- Read Less

News

View More

Related Experiences

View More

Related Professionals

NAME TITLE TELEPHONE CONTACT

Viewing 0 of 0 Results

View More

Publications

View More

Upcoming Events

Past Events

View More

Media Mentions

View More

Services

×

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.